A CONSORT diagram before and after random assignment of the APL204 study. Numbers in parentheses refer to the numbers of patients. ATRA, all-trans retinoic acid; DNR, daunorubicin; IDA, idarubicin; MIT, mitoxantrone; AraC, cytarabine; CR, complete remission.